Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1996 2
1997 13
1998 41
1999 54
2000 76
2001 101
2002 107
2003 129
2004 127
2005 128
2006 148
2007 136
2008 138
2009 151
2010 137
2011 126
2012 108
2013 157
2014 150
2015 111
2016 117
2017 131
2018 156
2019 106
2020 168
2021 143
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,695 results
Results by year
Filters applied: . Clear all
Page 1
Montelukast-induced adverse drug reactions: a review of case reports in the literature.
Calapai G, Casciaro M, Miroddi M, Calapai F, Navarra M, Gangemi S. Calapai G, et al. Pharmacology. 2014;94(1-2):60-70. doi: 10.1159/000366164. Epub 2014 Sep 2. Pharmacology. 2014. PMID: 25196099 Free article. Review.
Several clinical trials emphasized that montelukast can be considered a safe drug. However, recent evidence reconsidered the benefit/risk ratio of the use of montelukast for both paediatric and adult patients. ...A better understanding of the mechanisms causing ADRs …
Several clinical trials emphasized that montelukast can be considered a safe drug. However, recent evidence reconsidered the benefit/ …
Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
Glockler-Lauf SD, Finkelstein Y, Zhu J, Feldman LY, To T. Glockler-Lauf SD, et al. J Pediatr. 2019 Jun;209:176-182.e4. doi: 10.1016/j.jpeds.2019.02.009. Epub 2019 Mar 21. J Pediatr. 2019. PMID: 30905424
OBJECTIVE: To examine the association between montelukast prescription and neuropsychiatric events in children with asthma. ...Cases were matched to up to 4 controls on birth year, year of asthma diagnosis, and sex. The exposures were dispensed prescriptions for montelu
OBJECTIVE: To examine the association between montelukast prescription and neuropsychiatric events in children with asthma. ...Cases …
A meta-analysis of montelukast for recurrent wheeze in preschool children.
Hussein HR, Gupta A, Broughton S, Ruiz G, Brathwaite N, Bossley CJ. Hussein HR, et al. Eur J Pediatr. 2017 Jul;176(7):963-969. doi: 10.1007/s00431-017-2936-6. Epub 2017 Jun 1. Eur J Pediatr. 2017. PMID: 28567533 Free PMC article. Review.
The pooled results of the continuous regimen showed no significant difference in the number of wheezing episodes between the montelukast and placebo groups (MD -0.40, 95% CI -1.00 to 0.19; mean for montelukast 2.05 vs placebo 2.37 (p = 0.18)). ...What is Known: Curr …
The pooled results of the continuous regimen showed no significant difference in the number of wheezing episodes between the montelukast
Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
Zhang HP, Jia CE, Lv Y, Gibson PG, Wang G. Zhang HP, et al. Allergy Asthma Proc. 2014 Jul-Aug;35(4):278-87. doi: 10.2500/aap.2014.35.3745. Allergy Asthma Proc. 2014. PMID: 24992547 Review.
In acute asthma, montelukast could statistically improve peak expiratory flow percent predicted (p = 0.008) and reduce systemic corticosteroid intake (p = 0.005). Montelukast had low risk in hoarseness and insomnia. Our meta-analysis suggests that montelukast
In acute asthma, montelukast could statistically improve peak expiratory flow percent predicted (p = 0.008) and reduce systemic corti …
Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Mahatme MS, et al. Indian J Pharmacol. 2016 Nov-Dec;48(6):649-653. doi: 10.4103/0253-7613.194854. Indian J Pharmacol. 2016. PMID: 28066101 Free PMC article. Clinical Trial.

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was less in montelukast-levocetirizine group than in montelukast-fexofenadine group. CONCLUSION: The decrease in TNSS was more in

The mean change of TNSS, i.e., 9.46 was significant (P < 0.05) in montelukast-fexofenadine group. The cost-effectiveness ratio was

Neuropsychiatric side effects of montelukast.
Kovesi T. Kovesi T. J Pediatr. 2019 Sep;212:248. doi: 10.1016/j.jpeds.2019.05.019. Epub 2019 Jun 8. J Pediatr. 2019. PMID: 31182219 No abstract available.
The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis.
Wei C. Wei C. Biomed Pharmacother. 2016 Oct;83:989-997. doi: 10.1016/j.biopha.2016.08.003. Epub 2016 Aug 11. Biomed Pharmacother. 2016. PMID: 27522261 Review.
METHODS: We searched the databases of Pubmed, the Cochrane Library, Nature and Science as well as Wanfang data and CNKI from 2000 to March 2016, using key words "Montelukast SAH" or "H1-antihistamine Montelukast", or "Loratadine Montelukast", or "Desloratadin …
METHODS: We searched the databases of Pubmed, the Cochrane Library, Nature and Science as well as Wanfang data and CNKI from 2000 to March 2 …
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Chen X, Zhang X, Pan J. Chen X, et al. Med Sci Monit. 2019 Mar 13;25:1886-1893. doi: 10.12659/MSM.912774. Med Sci Monit. 2019. PMID: 30862773 Free PMC article.
Currently, the efficacy and safety of montelukast sodium in treating BPD has been revealed, however, the precise molecular mechanism of the effect of montelukast on BPD development remain largely unclear. Therefore, this study aimed to investigate the effect and mec …
Currently, the efficacy and safety of montelukast sodium in treating BPD has been revealed, however, the precise molecular mechanism …
Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase().
Aldea Perona A, García-Sáiz M, Sanz Álvarez E. Aldea Perona A, et al. Drug Saf. 2016 Jan;39(1):69-78. doi: 10.1007/s40264-015-0360-2. Drug Saf. 2016. PMID: 26620206
CONCLUSIONS: Neuropsychiatric disorders as side effects of montelukast were more frequently reported for children than for adults. ...Practitioners should be aware of the risk of neuropsychiatric events associated with montelukast use, and should advise the patient …
CONCLUSIONS: Neuropsychiatric disorders as side effects of montelukast were more frequently reported for children than for adults. .. …
Montelukast.
Markham A, Faulds D. Markham A, et al. Drugs. 1998 Aug;56(2):251-6; discussion 257. doi: 10.2165/00003495-199856020-00010. Drugs. 1998. PMID: 9711449 Review.
Montelukast is a selective antagonist of the leukotriene D4 (LTD4) receptor. ...Montelukast (5 mg/day) has also demonstrated efficacy in childhood asthma. ...
Montelukast is a selective antagonist of the leukotriene D4 (LTD4) receptor. ...Montelukast (5 mg/day) has also demonstrated e
2,695 results